why is compounded tirzepatide banned Explained: Key Facts to Know Compounded Tirzepatide: Legal & Safe

Clinical trials have demonstrated that the use of 2.4 mg of semaglutide once a week, combined with lifestyle intervention, led to a persistent and clinically significant reduction in body weight, with an average reduction of 14.9%

Medication can look perfectly normal while being both ineffective and unsafe

SURMOUNT-1: Jastreboff AM, et al

Taking doses too close together can increase side effects

It is also much more affordable than metreleptin

Therefore, our study examined the cardioprotective effects of tirzepatide (TZT), a novel glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide 1 (GLP-1) receptor agonist